Definitive Healthcare Corp. (DH)

Definitive Healthcare Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	241.52	252.2	251.42	222.65	166.15
Revenue Growth (YoY)	-4.23%	0.31%	12.92%	34.00%	40.43%
Cost of Revenue	37.95	40.68	34.74	25.87	19.42
Gross Profit	203.57	211.52	216.68	196.79	146.73
Selling, General & Admin	133.26	133.07	153.4	141.15	89.25
Research & Development	34.78	36.52	42.44	34.89	18.57
Amortization of Goodwill & Intangibles	20.29	14.05	12.74	16.76	21.27
Operating Expenses	224.15	221.26	247.59	232.94	167.76
Operating Income	-20.58	-9.74	-30.91	-36.15	-21.03
Interest Expense	-11.29	-14.84	-15.2	-11.2	-25.9
Interest & Investment Income	6.95	14.59	13.64	2.79	0.03
Other Non Operating Income (Expenses)	19.86	77.32	23.18	10.58	0.29
EBT Excluding Unusual Items	-5.06	67.33	-9.29	-33.99	-46.61
Merger & Restructuring Charges	-11.59	-14.01	-11.19	-6.64	-2.52
Impairment of Goodwill	-196.06	-688.85	-287.4	-	-
Other Unusual Items	3.46	1.78	-0.3	-1.25	-13.64
Pretax Income	-209.26	-633.75	-308.18	-41.88	-62.77
Income Tax Expense	-9.96	-42.3	-18.55	-17.7	-0.44
Earnings From Continuing Operations	-199.3	-591.45	-289.63	-24.18	-62.32
Minority Interest in Earnings	60.37	178.32	87.24	16.96	10.42
Net Income	-138.93	-413.12	-202.39	-7.22	-51.91
Preferred Dividends & Other Adjustments	-	-	-	-	-34.07
Net Income to Common	-138.93	-413.12	-202.39	-7.22	-17.84
Shares Outstanding (Basic)	107	117	113	101	92
Shares Outstanding (Diluted)	107	117	113	101	92
Shares Change (YoY)	-8.56%	3.44%	11.52%	10.01%	-28.01%
EPS (Basic)	-1.30	-3.54	-1.79	-0.07	-0.19
EPS (Diluted)	-1.30	-3.54	-1.79	-0.07	-0.19
Free Cash Flow	37.06	45.85	38.21	27.25	18.48
Free Cash Flow Per Share	0.35	0.39	0.34	0.27	0.20
Gross Margin	84.28%	83.87%	86.18%	88.38%	88.31%
Operating Margin	-8.52%	-3.86%	-12.29%	-16.24%	-12.66%
Profit Margin	-57.52%	-163.81%	-80.50%	-3.24%	-10.74%
Free Cash Flow Margin	15.34%	18.18%	15.20%	12.24%	11.12%
EBITDA	35.53	41.93	20.84	20.75	38.92
EBITDA Margin	14.71%	16.62%	8.29%	9.32%	23.42%
D&A For EBITDA	56.11	51.67	51.75	56.9	59.95
EBIT	-20.58	-9.74	-30.91	-36.15	-21.03
EBIT Margin	-8.52%	-3.86%	-12.29%	-16.24%	-12.66%
Advertising Expenses	2.1	1.9	1.6	1.6	0.9

Updated Feb 26, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q